Clinical Trials Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca by ClinicalTrialsFeed • 2014/09/29 • 0 Comments Status: Recruiting, Condition Summary: Keratoconjunctivitis Sicca; Dry Eye Disease Full Story →